cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Molecular Templates Inc
9 own
20 watching
Current Price
$0.46
$0.01
(2.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
25.92M
52-Week High
52-Week High
1.23
52-Week Low
52-Week Low
0.31
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization25.92M
icon52-Week High1.23
icon52-Week Low0.31
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Molecular Templates Inc do?
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Read More
How much money does Molecular Templates Inc make?
News & Events about Molecular Templates Inc.
PR Newswire
2 months ago
Thinking about buying stock in Molecular Templates, Silvergate Capital, Barnes & Noble Education, Coinbase Global, or Rivian Automotive? Thinking about buying stock in Molecular Templates, Silvergate Capital, Barnes & Noble Education, Coinbase Global, or Rivian Automotive? PR...
Globe Newswire
2 months ago
AUSTIN, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, Molecular Templates, or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), to create novel ...
Globe Newswire
6 months ago
AUSTIN, Texas, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.(Nasdaq: MTEM, Molecular Templates, or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced ...
Globe Newswire
11 months ago
Presentations on the MT-6402 (PD-L1) and MT-5111(HER2) Phase I dose escalation programs demonstrate unique biology, continued tolerability, and dose-dependent pharmacodynamic effectsAUSTIN, Texas, June 06, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM, Molecular Templates or MTEM...
Globe Newswire
1 year ago
Event will feature a presentation by David Spigel, MD, chief scientific officer of the Sarah Cannon Research Institute Wednesday, April 13th @ 8:00 am ET AUSTIN, Texas, April 08, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, Molecular Templates, or MTEM or the Company), a ...
Frequently Asked Questions
Frequently Asked Questions
What is Molecular Templates Inc share price today?
plus_minus_icon
Can Indians buy Molecular Templates Inc shares?
plus_minus_icon
How can I buy Molecular Templates Inc shares from India?
plus_minus_icon
Can Fractional shares of Molecular Templates Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Molecular Templates Inc stocks?
plus_minus_icon
What is today’s traded volume of Molecular Templates Inc?
plus_minus_icon
What is today’s market capitalisation of Molecular Templates Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Molecular Templates Inc?
plus_minus_icon
What percentage is Molecular Templates Inc down from its 52-Week High?
plus_minus_icon
What percentage is Molecular Templates Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.46
$0.01
(2.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SOLID BIOSCIENCES INC
SOLID BIOSCIENCES INC
$6.16
$0.16 (2.67 %)
GAMIDA CELL LTD
GAMIDA CELL LTD
$1.96
$-0.02 (-1.01 %)
AVROBIO INC
AVROBIO INC
$1.18
$0.03 (2.61 %)
AUTOLUS THERAPEUTICS PLC
AUTOLUS THERAPEUTICS PLC
$2.83
$-0.22 (-7.21 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
SOLID BIOSCIENCES INC
SOLID BIOSCIENCES INC
$6.16
$0.16 (2.67 %)
GAMIDA CELL LTD
GAMIDA CELL LTD
$1.96
$-0.02 (-1.01 %)
AVROBIO INC
AVROBIO INC
$1.18
$0.03 (2.61 %)
AUTOLUS THERAPEUTICS PLC
AUTOLUS THERAPEUTICS PLC
$2.83
$-0.22 (-7.21 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00